Clinical Trial Update: FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating FOLFIRINOX followed by ipilimumab with a pancreatic tumor vaccine in metastatic pancreatic cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• FOLFIRINOX
• ipilimumab (ipilimumab)
• pancreatic tumor vaccine

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-05-06